世界の痛風治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gout Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2615 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、痛風治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NSAID、コルチコステロイド、コルヒチン、尿酸低下薬）、用途別市場規模（急性痛風、慢性痛風）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・痛風治療の市場動向 ・企業の競争状況、市場シェア ・痛風治療の種類別市場規模（NSAID、コルチコステロイド、コルヒチン、尿酸低下薬） ・痛風治療の用途別市場規模（急性痛風、慢性痛風） ・痛風治療の北米市場規模2016-2027（アメリカ、カナダ） ・痛風治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・痛風治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・痛風治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・痛風治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda Pharmaceutical Company、Novartis、AstraZeneca、GlaxoSmithKline、Merck、Regeneron Pharmaceuticals） ・結論

Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries.
Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.

Market Analysis and Insights: Global Gout Therapeutics Market
The global Gout Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gout Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gout Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gout Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gout Therapeutics market.

Global Gout Therapeutics Scope and Market Size
Gout Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gout Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents

Segment by Application
Acute Gout
Chronic Gout

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda Pharmaceutical Company
Novartis
AstraZeneca
GlaxoSmithKline
Merck
Regeneron Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gout Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Colchicine
1.2.5 Urate-Lowering Agents
1.3 Market by Application
1.3.1 Global Gout Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Gout
1.3.3 Chronic Gout
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gout Therapeutics Market Perspective (2016-2027)
2.2 Gout Therapeutics Growth Trends by Regions
2.2.1 Gout Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gout Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gout Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gout Therapeutics Industry Dynamic
2.3.1 Gout Therapeutics Market Trends
2.3.2 Gout Therapeutics Market Drivers
2.3.3 Gout Therapeutics Market Challenges
2.3.4 Gout Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gout Therapeutics Players by Revenue
3.1.1 Global Top Gout Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gout Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gout Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gout Therapeutics Revenue
3.4 Global Gout Therapeutics Market Concentration Ratio
3.4.1 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gout Therapeutics Revenue in 2020
3.5 Gout Therapeutics Key Players Head office and Area Served
3.6 Key Players Gout Therapeutics Product Solution and Service
3.7 Date of Enter into Gout Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gout Therapeutics Breakdown Data by Type
4.1 Global Gout Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gout Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gout Therapeutics Breakdown Data by Application
5.1 Global Gout Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gout Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gout Therapeutics Market Size (2016-2027)
6.2 North America Gout Therapeutics Market Size by Type
6.2.1 North America Gout Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gout Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gout Therapeutics Market Size by Type (2016-2027)
6.3 North America Gout Therapeutics Market Size by Application
6.3.1 North America Gout Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gout Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gout Therapeutics Market Size by Application (2016-2027)
6.4 North America Gout Therapeutics Market Size by Country
6.4.1 North America Gout Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gout Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gout Therapeutics Market Size (2016-2027)
7.2 Europe Gout Therapeutics Market Size by Type
7.2.1 Europe Gout Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gout Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gout Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gout Therapeutics Market Size by Application
7.3.1 Europe Gout Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gout Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gout Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gout Therapeutics Market Size by Country
7.4.1 Europe Gout Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gout Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gout Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gout Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gout Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gout Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gout Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gout Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gout Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gout Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gout Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gout Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gout Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gout Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gout Therapeutics Market Size (2016-2027)
9.2 Latin America Gout Therapeutics Market Size by Type
9.2.1 Latin America Gout Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gout Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gout Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gout Therapeutics Market Size by Application
9.3.1 Latin America Gout Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gout Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gout Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gout Therapeutics Market Size by Country
9.4.1 Latin America Gout Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gout Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gout Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gout Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gout Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gout Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gout Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gout Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gout Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gout Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gout Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gout Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gout Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gout Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda Pharmaceutical Company
11.1.1 Takeda Pharmaceutical Company Company Details
11.1.2 Takeda Pharmaceutical Company Business Overview
11.1.3 Takeda Pharmaceutical Company Gout Therapeutics Introduction
11.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2016-2021)
11.1.5 Takeda Pharmaceutical Company Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gout Therapeutics Introduction
11.2.4 Novartis Revenue in Gout Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Gout Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Gout Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Gout Therapeutics Introduction
11.5.4 Merck Revenue in Gout Therapeutics Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Gout Therapeutics Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2016-2021)
11.6.5 Regeneron Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gout Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NSAIDs
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Colchicine
Table 5. Key Players of Urate-Lowering Agents
Table 6. Global Gout Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gout Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gout Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Gout Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Gout Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Gout Therapeutics Market Share by Regions (2022-2027)
Table 12. Gout Therapeutics Market Trends
Table 13. Gout Therapeutics Market Drivers
Table 14. Gout Therapeutics Market Challenges
Table 15. Gout Therapeutics Market Restraints
Table 16. Global Gout Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Gout Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Therapeutics as of 2020)
Table 19. Ranking of Global Top Gout Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Gout Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gout Therapeutics Product Solution and Service
Table 23. Date of Enter into Gout Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gout Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Gout Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Gout Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Gout Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Gout Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Gout Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Gout Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Gout Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Gout Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Gout Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Gout Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Gout Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Gout Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Gout Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Gout Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Gout Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gout Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gout Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Gout Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Gout Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Gout Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Gout Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Gout Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Gout Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gout Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gout Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Gout Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Gout Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Takeda Pharmaceutical Company Company Details
Table 64. Takeda Pharmaceutical Company Business Overview
Table 65. Takeda Pharmaceutical Company Gout Therapeutics Product
Table 66. Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Takeda Pharmaceutical Company Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Gout Therapeutics Product
Table 71. Novartis Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Gout Therapeutics Product
Table 76. AstraZeneca Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Gout Therapeutics Product
Table 81. GlaxoSmithKline Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Gout Therapeutics Product
Table 86. Merck Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Regeneron Pharmaceuticals Company Details
Table 89. Regeneron Pharmaceuticals Business Overview
Table 90. Regeneron Pharmaceuticals Gout Therapeutics Product
Table 91. Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Regeneron Pharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gout Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. NSAIDs Features
Figure 3. Corticosteroids Features
Figure 4. Colchicine Features
Figure 5. Urate-Lowering Agents Features
Figure 6. Global Gout Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Acute Gout Case Studies
Figure 8. Chronic Gout Case Studies
Figure 9. Gout Therapeutics Report Years Considered
Figure 10. Global Gout Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gout Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gout Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Gout Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Gout Therapeutics Market Share by Players in 2020
Figure 15. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gout Therapeutics Revenue in 2020
Figure 17. Global Gout Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Gout Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gout Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Gout Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Gout Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gout Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Gout Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Gout Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gout Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gout Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gout Therapeutics Market Share by Region (2016-2027)
Figure 39. China Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gout Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Gout Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Gout Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gout Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gout Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gout Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takeda Pharmaceutical Company Revenue Growth Rate in Gout Therapeutics Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Gout Therapeutics Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Gout Therapeutics Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Gout Therapeutics Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Gout Therapeutics Business (2016-2021)
Figure 63. Regeneron Pharmaceuticals Revenue Growth Rate in Gout Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---